Literature DB >> 29167145

Impact of pharmacist intervention on influenza vaccine assessment and documentation in hospitalized psychiatric patients.

Stephanie Cotugno1, Gina Morrow2, Chandra Cooper2, Maribeth Cabie2, Sara Cohn2.   

Abstract

PURPOSE: Results of an initiative to improve assessment and documentation of the influenza vaccination status of adult psychiatric inpatients are reported.
METHODS: A prospective quality-improvement study was conducted at a large, tertiary care academic medical center with the aim of improving compliance with the Influenza Immunization (IMM-2) quality measure, which was added to the Inpatient Psychiatric Facility Quality Reporting (IPFQR) program in 2015 and requires assessment and documentation of influenza vaccination status in specified groups of psychiatric inpatients. The primary objective was to improve the IMM-2 IPFQR compliance rate to 100% during the 2015-16 influenza season from a rate of 55% during the 2014-15 influenza season through pharmacist interventions; secondary objectives included analysis of types of pharmacist interventions, rates of influenza vaccination status assessment and ordering, and rates of vaccine refusal by psychiatric disease state.
RESULTS: With pharmacist interventions, the IMM-2 IPFQR compliance rate was increased to 99% during the 2015-16 influenza season. Of the 1,413 patients included in the study population, 45% (n = 646) were targeted for pharmacist intervention. Influenza vaccine was ordered for 61% of the study population (n = 867 patients), with an overall refusal rate of 74% (n = 642). Differences in refusal rates by psychiatric diagnosis were not significant.
CONCLUSION: Pharmacist-conducted education of nurses and interventions to ensure completion of influenza vaccine assessments and documentation led to an improved IMM-2 IPFQR compliance rate at the study site.
Copyright © 2017 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  compliance; influenza; influenza vaccines; nursing; pharmacy; psychiatry

Mesh:

Substances:

Year:  2017        PMID: 29167145     DOI: 10.2146/ajhp160755

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  4 in total

1.  Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders.

Authors:  Amy Werremeyer; Jolene Bostwick; Carla Cobb; Tera D Moore; Susie H Park; Cristofer Price; Jerry McKee
Journal:  Ment Health Clin       Date:  2020-11-05

2.  Attitudes toward COVID-19 vaccination and willingness to pay: comparison of people with and without mental disorders in China.

Authors:  Fengyi Hao; Bokun Wang; Wanqiu Tan; Syeda Fabeha Husain; Roger S McIntyre; Xiangdong Tang; Ling Zhang; Xiaofan Han; Li Jiang; Nicholas W S Chew; Benjamin Yong-Qiang Tan; Bach Tran; Zhisong Zhang; Gia Linh Vu; Giang Thu Vu; Roger Ho; Cyrus S Ho; Vijay K Sharma
Journal:  BJPsych Open       Date:  2021-08-11

3.  Improving Influenza Vaccination Coverage Among Patients With COPD: A Pilot Project.

Authors:  Andrew Li; Yiong-Huak Chan; Mei Fong Liew; Rakshya Pandey; Jason Phua
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-15

Review 4.  Effectiveness of Educational Intervention on Influenza Vaccine Uptake: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Xiaoju Zhou; Xuequn Zhao; Jun Liu; Wenjie Yang
Journal:  Iran J Public Health       Date:  2020-12       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.